FDA Clearance Tracker · P150001-S028
MiniMed 630G Insulin Pump
Last checked: Nov 20, 2026Latest source record: Dec 20, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 20, 2017
Approved
Time to decision
51 days
Received Oct 30, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150001-S028
- Device name
- MiniMed 630G Insulin Pump
- Applicant
- Medtronic Minimed
- Applicant location
- Northridge, CA
- Received
- Oct 30, 2017
- Decided
- Dec 20, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150001
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for 1) minor design changes to the electronics board stack used in the 630G insulin pump; 2) a new supplier for the electronics board stack; 3) an updated pump software version; and 4) an extension to the 630G insulin pump shelf life from 185 days to 1095 days.
Source documents
Other decisions for Medtronic Minimed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261962 · Decided Jul 9, 2026 · 28 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.